- $13.02bn
- $13.59bn
- $4.03bn
- 99
- 60
- 63
- 87
Annual balance sheet for Hologic, fiscal year end - September 28th, USD millions except per share, conversion factor applied.
2020 September 26th | 2021 September 25th | 2022 September 24th | 2023 September 30th | 2024 September 28th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 701 | 1,170 | 2,340 | 2,723 | 2,334 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,029 | 943 | 618 | 626 | 600 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,222 | 3,169 | 3,862 | 4,185 | 3,823 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 572 | 648 | 551 | 580 | 630 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7,196 | 8,920 | 9,071 | 9,139 | 9,156 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,239 | 1,327 | 938 | 1,207 | 1,037 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 4,491 | 4,701 | 4,195 | 4,122 | 4,026 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 2,705 | 4,219 | 4,876 | 5,017 | 5,130 |
Total Liabilities & Shareholders' Equity | 7,196 | 8,920 | 9,071 | 9,139 | 9,156 |
Total Common Shares Outstanding |